{"podcast":{"title":"Lung Cancer Update","slug":"lung-cancer-update-827388","podcast_index_feed_id":827388,"rss_url":"https://feeds.captivate.fm/lung-cancer-update/","website_url":"https://www.researchtopractice.com/browse-tumor-types/lung-cancer","image_url":"https://artwork.captivate.fm/230421a8-7e2e-4fb0-b40c-3b50a1cbf78f/nstTehQJgx-Rm0qFgD_28hl9.png","author":"Dr. Neil Love","episode_count":56,"summary":"Featuring one-on-one interviews conducted by Dr Neil Love, this series bridges the gap between research and patient care by providing medical oncologists, hematologists and hematology/oncology fellows ongoing access to the perspectives and opinions of national and international research leaders with an expertise in thoracic oncology.","last_synced_at":"2026-07-15T06:20:06.840223+00:00","page_url":"https://stenobird.com/podcast/lung-cancer-update-827388"},"episode":{"title":"For Oncology Nurses: Strategies to Safely and Effectively Implement Antibody-Drug Conjugates — Proceedings from the 2026 Annual ONS Congress","slug":"for-oncology-nurses-strategies-to-safely-and-effectively-implement-antibody-drug-conjugates-proceedings-from-the-2026-annual-ons-congress","published_at":"2026-07-08T13:00:00+00:00","page_url":"https://stenobird.com/podcast/lung-cancer-update-827388/for-oncology-nurses-strategies-to-safely-and-effectively-implement-antibody-drug-conjugates-proceedings-from-the-2026-annual-ons-congress","show_page_url":"https://stenobird.com/podcast/lung-cancer-update-827388","url":"https://lung-cancer-update.captivate.fm/episode/5899-ons2026-adc","audio_url":"https://dts.podtrac.com/redirect.mp3/episodes.captivate.fm/episode/32286ec8-3517-4945-83d7-94f96c5cb661.mp3","summary":"Featuring perspectives from Ms Courtney Arn, Ms Jamie Carroll, Dr Edward B Garon, Dr Heather McArthur and Dr Kathleen N Moore, moderated by Dr Moore, including the following topics: Introduction (0:00) Overview of Antibody-Drug Conjugates (ADCs) (2:07) Current and Future Role of HER2-Targeted ADCs for Breast Cancer (6:23) Currently Available ADCs for Gynecologic Cancer Management (26:37) Currently Available ADCs for Lung Cancer Management (44:07) Current and Future Role of TROP2-Targeted ADCs for Metastatic Breast Cancer (56:55) Other ADCs That May Soon Reach the Clinic for Advanced Gynecologic Cancers (1:15:07) Promising Investigational Strategies Employing ADCs for Lung Cancer (1:25:01) NCPD information and select publications","meta_description":"Featuring perspectives from Ms Courtney Arn, Ms Jamie Carroll, Dr Edward B Garon, Dr Heather McArthur and Dr Kathleen N Moore, moderated by Dr Moore, incl…","key_points":[],"chapters":[],"topics":[],"duration_seconds":5334,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/lung-cancer-update-827388/episodes/for-oncology-nurses-strategies-to-safely-and-effectively-implement-antibody-drug-conjugates-proceedings-from-the-2026-annual-ons-congress/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/lung-cancer-update-827388/for-oncology-nurses-strategies-to-safely-and-effectively-implement-antibody-drug-conjugates-proceedings-from-the-2026-annual-ons-congress.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}